— At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%;

 — At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%;

Is Omicron a COVID-19 variant of concern?

Does the Omicron variant of COVID-19 cause severe illness?

Have cases of COVID-19 variant Omicron been mild so far?

What are the organs most affected by COVID‐19?

Molnupiravir, an Oral Antiviral Treatment for COVID-19